
IPO Update: PainReform Readies U.S. IPO Plan
Quick Take PainReform (PRFX) intends to raise $23 million from the sale of its common stock in an IPO, according to an amended registration statement. The company is developing a reformulated pain relief medication for post-operative pain reduction. PRFX …